Retinal Dystrophy clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
Personalized Antisense Oligonucleotide Therapy for a Single Participant With PRPH2 Mutation Associated With Retinal Dystrophy
Sorry, in progress, not accepting new patients
This research project entails delivery of a personalized antisense oligonucleotide (ASO) drug designed for a single participant with Retinal Dystrophy due to PRPH2 mutation
San Diego, California
Last updated: